首页 > 市场调查报告书 > 食物/饮料

机能性食品

市场调查报告书

商品编码

1542892

全球后生元食品补充品市场 - 2024-2031

Global Postbiotics Food Supplements Market - 2024-2031

出版日期: 2024年08月26日 | 出版商:

DataM Intelligence | 英文 219 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

概述

2023年，全球后生元食品补充剂市场达到1,080万美元，预计2031年将达到2,730万美元，2024-2031年预测期间复合年增长率为10.5%。

由于后生元具有经过科学验证的健康益处、其高稳定性以及在各种产品形式中的多功能性，后生元食品补充剂市场正在获得巨大的吸引力。后生元是益生菌微生物的非活细菌产物或代谢副产物，旨在解决广泛的健康问题，包括肠道健康、免疫和炎症，从而推动消费者兴趣和市场成长。

最近的研究表明，后生元可以比益生菌提供更直接的免疫调节作用。特定的后生元菌株已证明巨噬细胞中 IL-12 的产量有更高的增加，这对于防御传染病至关重要。这会导致免疫反应发生有益的变化，增强 IL-10 和 IL-12 的增殖，以及脾臟细胞和树突状细胞中 IFN-Y 的产生。

后生元的直接免疫调节作用提供了卓越的健康益处，并减轻了与益生菌相关的潜在负面影响。这使得后生元成为免疫受损族群（例如老年人或移植患者）更安全的替代品。

此外，后生元为产品创新提供了重要机会，特别是在益生菌效果较差的环境中。后生元的一个关键优势是其稳定性，这使得它们对储存条件不太敏感，并且适合各种递送形式，包括片剂和胶囊。这种多功能性提高了消费者的便利性并扩大了市场潜力。

市场动态

人们对后生元改善人类健康的认识不断提高

人们对后生元在健康和保健方面的认识和采用不断提高，正在推动功能性食品和膳食补充剂行业的显着增长。后生元由益生菌产生的代谢物和成分组成，透过各种机制增强人类健康，无需消耗活微生物，从而提供独特的价值主张。消费者对促进健康的产品的需求不断增长、对肠道健康的更加关注以及对传统益生菌的经过科学验证的非生命替代品的日益青睐，推动了这一趋势。

根据 2023 年 1 月发表在学术社区百科全书 (MDPI) 上的一篇文章，后生元（微生物发酵过程中产生的生物活性化合物）已成为增强健康的一个有前景的前沿领域。这些化合物，包括乳酸、细菌素和胞外多醣 (EPS)，表现出显着的抗菌特性。例如，乳酸和细菌素可直接抑制革兰氏阴性病原体，突显它们在控制病原体感染和支持肠道健康方面的作用。值得注意的是，源自乳酸桿菌和双歧桿菌菌株的后生元已显示出对抗肠道侵袭性大肠桿菌和其他有害微生物的功效，这对于维持平衡的微生物群和预防胃肠道疾病至关重要。

与活益生菌相比，后生元的市场潜力因其稳定性和安全性而得到增强，活益生菌经常面临与保质期和监管障碍相关的挑战。随着消费者和医疗保健从业者越来越了解后生元的优势，包括其支持肠道健康和增强免疫功能的能力，需求预计会增加。投资后生元的公司将从越来越多具有健康意识的消费者寻求科学支持、有效和安全的膳食补充剂中受益。

越来越多的科学证据支持后生元的益处

科学研究越来越多地验证后生元的健康益处，增强了它们在食品补充剂市场的吸引力。后生元是益生菌在发酵过程中产生的生物活性化合物，因其在支持肠道健康、免疫功能和整体健康方面的稳定性、安全性和有效性而受到关注。新兴研究强调了它们在调节肠道微生物组、减少发炎和改善代谢健康方面的作用，进一步巩固了它们的价值主张。越来越多的证据支持将后生元纳入膳食补充剂，将后生元定位为传统益生菌的科学基础的稳定替代品，并推动该领域的市场成长。

根据国家医学图书馆的数据，到 2022 年，坏死性小肠结肠炎 (NEC) 将成为一种严重影响婴儿发病率和死亡率的疾病。这强调了对有效和安全的预防性治疗的迫切需求。最近的治疗研究已确定益生菌是 NEC 的主要潜在干预措施，特别是对于早产儿。然而，与安全性和剂量相关的担忧限制了益生菌在这些弱势群体的临床环境中的实际应用。

儘管仍在研究中，后生元为活益生菌提供了一种有前途的替代或补充疗法。这些源自于细菌结构，即使在微生物被热诱导破坏后仍保留生物活性。最近对未成熟肠道的小鼠模型进行的一项研究表明，热灭活的鼠李糖乳桿菌 GG (LGG) 在增强肠道屏障功能方面表现出与活益生菌相当的治疗效果。

监管挑战和合规问题

儘管人们越来越意识到后生元食品补充剂的潜在健康益处，但监管挑战和合规问题对后生元食品补充剂市场构成了重大限制。

包括后生元在内的膳食补充剂的监管环境在不同地区和国家之间存在很大差异，这给製造商在产品註册、标籤要求和健康声明证实方面带来了复杂性。

包括欧洲食品安全局（EFSA）和欧洲药典在内的许多司法管辖区已经制定了益生菌和益生元的标准，但尚未制定针对后生元的具体法规。同样，在美国，食品和药物管理局 (FDA) 没有为后生元提供具体指南，其监管状态需要根据适用于类似产品的现有类别来确定。这种监管上的不确定性可能会导致后生元在不同市场的行销和销售方式不一致。

细分市场分析

全球后生元食品补充剂市场根据类型、形式、应用、配销通路和地区进行细分。

食品和饮料应用中后生元的使用需求激增

近年来，后生元已成为食品和饮料领域引人注目的成分，为产品开发的创新和差异化提供了巨大的潜力。后生元包括细菌裂解物、酶、胜肽和代谢物，由于其在一系列温度和 pH 水平下的稳定性而受到关注。这种稳定性使製造商能够将后生元融入各种食品和饮料产品中，而不会影响其功能，从而呈现出显着的技术和财务优势。

后生元在食品和饮料产品的应用多种多样，涵盖乳製品和非乳製品领域。例如，源自发酵过程的后生元常见于克菲尔、康普茶、优格和腌製蔬菜等产品。后生元的自然融入增强了这些产品的功能特性，满足了消费者对功能性和健康促进食品日益增长的需求。

后生元的加入也可以策略性地用于增强食品的感官和理化特性。例如，乳酸菌（LAB）产生的胞外多醣（EPS）可以改善乳製品的质地和口感，提供市场竞争优势。此外，后生元可以促进食物富含必需维生素和生物活性化合物。例如，发酵过程可以提高谷物中 B 群维生素的含量，补偿碾磨和加工过程中的营养损失。

市场地域占有率

亚太地区对后生元食品补充剂的需求

中国、印度和日本等亚太国家的出生率不断上升，人们越来越重视孕产妇和儿童健康。这种人口趋势是对营养补充剂（包括后生元）需求的重要推动力，人们认识到后生元具有支持产后孕产妇健康和促进婴儿发育的潜力。

在文化上，中国和印度等国家非常重视孕产妇福祉和新生儿的健康。后生元因其在促进肠道健康、增强免疫功能以及与优先考虑自然疗法和预防性健康措施的传统医疗实践相一致方面的好处而受到越来越多的追捧。

儘管与益生菌和益生元相比，后生元是一个较新的领域，但它正在成为一个重要的关注领域。益生菌产生的这些代谢物因其潜在的健康益处而获得认可，包括抗发炎和免疫调节作用。后生元的稳定性和功效正在受到严格审查，正在进行的研究旨在验证其健康声明并确保监管合规性。

COVID-19 影响分析

COVID-19 大流行对后生元食品补充剂市场产生了重大影响，既有正面的影响，也有负面的影响。从积极的一面来看，大流行期间健康意识的提高导致消费者对包括后生元在内的健康和保健产品的兴趣增加。

许多消费者转向膳食补充剂来增强免疫系统、支持整体健康和控制压力，导致后生元产品的需求激增。这种趋势在寻求增强产后健康和福祉的新妈妈中尤其明显，推动了后生元食品补充剂市场的成长。

不利的一面是，疫情对全球供应链造成了严重破坏，影响了后生元补充剂所需原料的供应和成本。封锁、旅行限制和劳动力短缺阻碍了製造和分销流程，导致延误和成本增加。此外，疫情引发的经济低迷影响了消费者的购买力，可能会限制市场成长，因为一些消费者可能会削减非必要支出。

俄乌战争影响分析

俄罗斯-乌克兰战争对全球供应链产生了重大影响，影响了后生元食品补充剂市场。两国都是膳食补充剂中使用的各种原料和成分（包括后生元）的主要生产商和供应商。衝突导致这些关键零件的生产和出口中断，导致全球製造商供应短缺并增加生产成本。

该地区的不稳定也导致能源价格波动，进一步推高製造和分销成本。因此，后生元食品补充剂市场的公司在维持稳定的供应和管理增加的成本方面面临挑战，这可能会影响产品定价和消费者的可用性。

此外，地缘政治紧张局势造成不确定性并影响消费者信心，从而影响了市场动态。对俄罗斯实施的经济制裁和贸易限制使国际贸易和商业运作复杂化，导致市场活动延误和不确定性。这对欧洲市场的影响尤其严重，因为欧洲市场对东欧原料的依赖程度很高。

按类型

短链脂肪酸

脂多醣

胞外多醣

酵素

细胞壁碎片

其他的

按形式

胶囊和片剂

液体

粉末

其他的

按申请

消化系统健康

肠道微生物群/微生物组平衡

消化

便秘

腹胀

其他的

免疫支持

皮肤健康

体重管理

运动营养

心理健康

睡觉

认识

情绪

沮丧

一般健康

其他的

按配销通路

超市/大卖场

药局和药局

便利商店

网路零售商

其他分销管道

按地区

北美洲

我们

加拿大

墨西哥

欧洲

德国

英国

法国

义大利

俄罗斯

欧洲其他地区

南美洲

巴西

阿根廷

南美洲其他地区

亚太

中国

印度

日本

澳洲

亚太其他地区

中东和非洲

主要进展

2024 年 2 月，凯爱瑞集团推出了 Plenibiotic（干酪乳桿菌亚种 327），这是一种源自大米的后生元，适用于人类和宠物补充剂形式。这种成分得到了科学研究的支持，证明了它对消化和皮肤健康的益处。 Plenibiotics 在各种温度和环境下都非常稳定，即使在最小剂量下也能确保其保质期和有效性。

2023 年 10 月，利乐与 AB Biotek 合作推出了一系列创新的后生元食品解决方案。这些后生元以粉末形式提供，可以在超高温 (UHT) 加工的混合阶段有效地掺入。这种整合适用于多种产品，包括饮料、乳製品、冰淇淋和起司。

The postbiotics food supplements market is gaining significant traction due to the scientifically validated health benefits of postbiotics, their high stability profile, and their versatility across various product formats. Postbiotics, the non-viable bacterial products or metabolic byproducts from probiotic microorganisms, are positioned to address a broad spectrum of health issues, including gut health, immunity, and inflammation, driving consumer interest and market growth.

Recent studies indicate that postbiotics can offer more direct immunomodulation effects than probiotics. Specific postbiotic strains have demonstrated a higher increase in IL-12 production in macrophages, which is pivotal for defending against infectious diseases. This leads to beneficial changes in the immune response, enhancing the proliferation of IL-10 and IL-12, and the production of IFN-Y in splenocytes and dendritic cells.

The direct immunomodulation effect of postbiotics provides superior health benefits and mitigates potential negative effects associated with probiotics. This makes postbiotics a safer alternative for immune-compromised populations, such as the elderly or transplant patients.

Furthermore, postbiotics present significant opportunities for product innovation, especially in environments where probiotics are less effective. A key advantage of postbiotics is their stability, which makes them less sensitive to storage conditions and suitable for various delivery formats, including tablets and capsules. This versatility enhances consumer convenience and broadens market potential.

Market Dynamics

Rising Awareness of Postbiotics in Improving Human Health

The increasing awareness and adoption of postbiotics in health and wellness are driving significant growth in the functional foods and dietary supplements sectors. Postbiotics, comprising metabolites and components produced by probiotics, offer a unique value proposition by enhancing human health through various mechanisms without necessitating live microbial consumption. This trend is fueled by rising consumer demand for health-boosting products, a greater focus on gut health, and a growing inclination towards scientifically validated, non-living alternatives to traditional probiotics.

According to an article published in the Scholarly Community Encyclopedia (MDPI) in January 2023, Postbiotics, the bioactive compounds produced during microbial fermentation, have emerged as a promising frontier in health enhancement. These compounds, including lactic acid, bacteriocins, and exopolysaccharides (EPS), exhibit significant antimicrobial properties. For instance, lactic acid and bacteriocins demonstrate direct inhibition of Gram-negative pathogens, highlighting their role in managing pathogenic infections and supporting gut health. Notably, postbiotics derived from Lactobacillus and Bifidobacterium strains have shown efficacy in combating enteroinvasive E. coli and other harmful microorganisms, which can be crucial for maintaining a balanced microbiota and preventing gastrointestinal diseases.

The market potential for postbiotics is bolstered by their stability and safety profiles compared to live probiotics, which often face challenges related to shelf-life and regulatory hurdles. As consumers and healthcare practitioners become more informed about the advantages of postbiotics, including their ability to support gut health and enhance immune function, demand is expected to rise. Companies investing in postbiotics stand to benefit from a growing segment of health-conscious consumers seeking scientifically backed, effective, and safe dietary supplements.

Growing Scientific Evidence Supporting postbiotic Benefits

Scientific research increasingly validates the health benefits of postbiotics, enhancing their appeal in the food supplements market. Postbiotics, the bioactive compounds produced by probiotics during fermentation, are gaining traction due to their stability, safety, and effectiveness in supporting gut health, immune function, and overall well-being. Emerging studies highlight their role in modulating the gut microbiome, reducing inflammation, and improving metabolic health, further solidifying their value proposition. This growing body of evidence supports their incorporation into dietary supplements, positioning postbiotics as a scientifically backed, stable alternative to traditional probiotics and fueling market growth in this segment.

According to the National Library of Medicine, in 2022, necrotizing enterocolitis (NEC) is a critical condition contributing significantly to infant morbidity and mortality. This underscores the urgent need for effective and safe prophylactic treatments. Recent therapeutic studies have identified probiotics as a leading potential intervention for NEC, particularly in preterm infants. However, concerns related to safety and dosage have limited the practical application of probiotics in clinical settings for these vulnerable populations.

Though still under research, postbiotics present a promising alternative or complementary therapy to live probiotics. These are derived from bacterial structures that retain biological activity even after heat-induced destruction of the microorganisms. A recent study in a murine model of immature intestines demonstrated that heat-killed Lactobacillus rhamnosus GG (LGG) exhibits comparable therapeutic efficacy to live probiotics in enhancing intestinal barrier function.

Regulatory Challenges and Compliance Issues

Regulatory challenges and compliance issues pose significant restraints to the postbiotic food supplements market, despite growing awareness of their potential health benefits.

The regulatory landscape for dietary supplements, including postbiotics, varies widely across different regions and countries, creating complexities for manufacturers in terms of product registration, labeling requirements, and health claims substantiation.

Many jurisdictions, including the European Food Safety Authority (EFSA) and the European Pharmacopoeia, have established standards for probiotics and prebiotics, but they have yet to create specific regulations for postbiotics. Similarly, in the United States, the Food and Drug Administration (FDA) has not provided specific guidelines for postbiotics, leaving their regulatory status to be determined based on existing categories applicable to similar products. This regulatory uncertainty can lead to inconsistencies in how postbiotics are marketed and sold across different markets.

Market Segment Analysis

The global postbiotics food supplements market is segmented based on type, form, application, distribution channel, and region.

The Surging Demand For The Use Of Postbiotics In The Food And Beverage Applications

In recent years, postbiotics have emerged as a compelling ingredient within the food and beverage sector, offering substantial potential for innovation and differentiation in product development. Postbiotics, which include bacterial lysates, enzymes, peptides, and metabolites, are gaining traction due to their stability across a range of temperatures and pH levels. This stability allows manufacturers to incorporate postbiotics into various food and beverage products without compromising their functionality, presenting significant technical and financial advantages.

The application of postbiotics in food and beverage products is diverse, encompassing dairy and non-dairy segments. For instance, postbiotics derived from fermentation processes are commonly found in products like kefir, kombucha, yogurt, and pickled vegetables. This natural incorporation of postbiotics enhances the functional profile of these products, catering to the growing consumer demand for functional and health-promoting foods.

The incorporation of postbiotics can also be strategically employed to enhance the sensory and physicochemical attributes of food products. For example, extracellular polysaccharides (EPS) produced by lactic acid bacteria (LAB) can improve the texture and mouthfeel of dairy products, providing a competitive edge in the market. Additionally, postbiotics can facilitate the enrichment of foods with essential vitamins and bioactive compounds. The fermentation process, for instance, can boost levels of B vitamins in cereal grains, compensating for nutrient losses during milling and processing.

Market Geographical Share

Demand for Postbiotics Food Supplements in Asia-Pacific

Asia-Pacific countries such as China, India, and Japan are experiencing rising birth rates and a growing emphasis on maternal and child health. This demographic trend is a significant driver for the demand for nutritional supplements, including postbiotics, which are recognized for their potential to support maternal health during the postnatal period and enhance infant development.

Culturally, countries like China and India place strong emphasis on maternal well-being and the health of newborns. Postbiotics are increasingly sought after due to their perceived benefits in promoting gut health, bolstering immune function, and aligning with traditional healthcare practices that prioritize natural remedies and preventive health measures.

Postbiotics, although a newer segment compared to probiotics and prebiotics, are emerging as a key area of interest. These metabolites produced by probiotic bacteria are gaining recognition for their potential health benefits, including anti-inflammatory and immune-modulating effects. The stability and efficacy of postbiotics are under scrutiny, with ongoing research aimed at validating their health claims and ensuring regulatory compliance.

COVID-19 Impact Analysis

The COVID-19 pandemic has significantly impacted the postbiotic food supplements market, both positively and negatively. On the positive side, heightened health awareness during the pandemic has led to increased consumer interest in health and wellness products, including postbiotics.

Many consumers have turned to dietary supplements to boost their immune systems, support overall health, and manage stress, leading to a surge in demand for postbiotic products. This trend has been particularly pronounced among new mothers seeking to enhance their postpartum health and well-being, driving growth in the postbiotic food supplements market.

On the negative side, the pandemic has caused significant disruptions to global supply chains, affecting the availability and cost of raw materials necessary for postbiotic supplements. Lockdowns, travel restrictions, and labor shortages have hampered manufacturing and distribution processes, leading to delays and increased costs. Additionally, the economic downturn induced by the pandemic has affected consumer purchasing power, potentially limiting market growth as some consumers may cut back on non-essential spending.

Russia-Ukraine War Impact Analysis

The Russia-Ukraine war has had significant repercussions on the global supply chain, impacting the postbiotic food supplements market. Both countries are major producers and suppliers of various raw materials and ingredients used in dietary supplements, including postbiotics. The conflict has led to disruptions in the production and export of these critical components, resulting in supply shortages and increased production costs for manufacturers worldwide.

The instability in the region has also caused fluctuations in energy prices, further driving up manufacturing and distribution costs. Consequently, companies in the postbiotic food supplements market have faced challenges in maintaining consistent supply and managing increased costs, which can affect product pricing and availability for consumers.

Moreover, the geopolitical tension has influenced market dynamics by creating uncertainty and affecting consumer confidence. Economic sanctions and trade restrictions imposed on Russia have complicated international trade and business operations, causing delays and uncertainties in market activities. This has particularly impacted European markets, where the dependence on Eastern European raw materials is substantial.

By Type

Short-chain fatty acids

Lipopolysaccharides

Exopolysaccharides

Enzymes

Cell Wall Fragments

Others

By Form

Capsules & Tablets

Liquid

Powder

Others

By Application

Digestive Health

Gut Microbiota/Microbiome Balance

Digestion

Constipation

Bloating

Others

Immune Support

Skin Health

Weight Management

Sports Nutrition

Mental Health

Sleep

Cognition

Mood

Depression

General Wellness

Others

By Distribution Channel

Supermarkets/Hypermarkets

Pharmacies and Drug Stores

Convenience Stores

Online Retailers

Other Distribution Channels

By Region

North America

U.S.

Canada

Mexico

Europe

Germany

France

Italy

Russia

Rest of Europe

South America

Brazil

Argentina

Rest of South America

Asia-Pacific

China

India

Japan

Australia

Rest of Asia-Pacific

Middle East and Africa

Key Developments

In February 2024, Kerry Group introduced a Plenibiotic (Lactobacillus casei subsp. 327), a rice-derived postbiotic suitable for both human and pet supplement formats. This ingredient is supported by scientific research demonstrating its benefits for digestive and skin health. Plenibiotics are notably stable across various temperatures and environments, ensuring their shelf life and effectiveness even at minimal dosages.

In October 2023, Tetra Pak collaborated with AB Biotek to introduce a range of innovative postbiotic food solutions. These postbiotics, available in powder form, can be efficiently incorporated during the mixing stage of Ultra High Temperature (UHT) processing. This integration is applicable to a variety of products, including beverages, dairy items, ice cream, and cheese.

Competitive Landscape

The major global players in the market include ADM, Cargill, Incorporated., ABbiotek Health, Tetra Pak International S.A., DSM, AB-BIOTICS, SA, Sabinsa, Postbiotica Srl, Lesaffre, and Lactobio A/S.

Why Purchase the Report?

To visualize the global postbiotic food supplements market segmentation based on type, form, application, distribution channel, and region as well as understand key commercial assets and players.

Identify commercial opportunities by analyzing trends and co-development.

Excel data sheet with numerous data points of postbiotic food supplements market-level with all segments.

PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.

Product mapping available as Excel consisting of key products of all the major players.

The global postbiotic food supplements market report would provide approximately 70 tables, 66 figures, and 219 Pages.

Target Audience 2024

Manufacturers/ Buyers

Industry Investors/Investment Bankers

Research Professionals

Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Type
3.2. Snippet by Form
3.3. Snippet by Application
3.4. Snippet by Distribution Channel
3.5. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Rising Awareness of postbiotics on improving human health
  - 4.1.1.2. Growing Scientific Evidence Supporting postbiotic Benefits
- 4.1.2. Restraints
  - 4.1.2.1. Regulatory Challenges and Compliance Issues
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Russia-Ukraine War Impact Analysis
5.6. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Short-chain fatty acids*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Lipopolysaccharides
7.4. Exopolysaccharides
7.5. Enzymes
7.6. Cell Wall Fragments
7.7. Others

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Capsules & Tablets*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Powder
8.4. Liquid
8.5. Others

9. By Application

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 9.1.2. Market Attractiveness Index, By Application
9.2. Digestive Health*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 9.2.3. Gut Microbiota/Microbiome Balance
- 9.2.4. Digestion
- 9.2.5. Constipation
- 9.2.6. Bloating
- 9.2.7. Others
9.3. Immune Support
9.4. Skin Health
9.5. Weight Management
9.6. Sports Nutrition
9.7. Mental Health
- 9.7.1. Sleep
- 9.7.2. Cognition
- 9.7.3. Mood
- 9.7.4. Depression
9.8. General Wellness
9.9. Others

10. By Distribution Channel

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 10.1.2. Market Attractiveness Index, By Distribution Channel
10.2. Supermarkets/Hypermarkets*
- 10.2.1. Introduction
- 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Pharmacies and Drug Stores
10.4. Convenience Stores
10.5. Online Retailers
10.6. Other Distribution Channels

11. By Region

11.1. Introduction
- 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 11.1.2. Market Attractiveness Index, By Region
11.2. North America
- 11.2.1. Introduction
- 11.2.2. Key Region-Specific Dynamics
- 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.2.7.1. U.S.
  - 11.2.7.2. Canada
  - 11.2.7.3. Mexico
11.3. Europe
- 11.3.1. Introduction
- 11.3.2. Key Region-Specific Dynamics
- 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.3.7.1. Germany
  - 11.3.7.2. UK
  - 11.3.7.3. France
  - 11.3.7.4. Italy
  - 11.3.7.5. Spain
  - 11.3.7.6. Rest of Europe
11.4. South America
- 11.4.1. Introduction
- 11.4.2. Key Region-Specific Dynamics
- 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.4.7.1. Brazil
  - 11.4.7.2. Argentina
  - 11.4.7.3. Rest of South America
11.5. Asia-Pacific
- 11.5.1. Introduction
- 11.5.2. Key Region-Specific Dynamics
- 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 11.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 11.5.7.1. China
  - 11.5.7.2. India
  - 11.5.7.3. Japan
  - 11.5.7.4. Australia
  - 11.5.7.5. Rest of Asia-Pacific
11.6. Middle East and Africa
- 11.6.1. Introduction
- 11.6.2. Key Region-Specific Dynamics
- 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Type
- 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
- 11.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel

12. Competitive Landscape

12.1. Competitive Scenario
12.2. Market Positioning/Share Analysis
12.3. Mergers and Acquisitions Analysis

13. Company Profiles

13.1. ADM *
- 13.1.1. Company Overview
- 13.1.2. Product Portfolio and Description
- 13.1.3. Financial Overview
- 13.1.4. Key Developments
13.2. Cargill, Incorporated
13.3. ABbiotek Health
13.4. Tetra Pak International S.A.
13.5. DSM
13.6. AB-BIOTICS, SA
13.7. Sabinsa
13.8. Postbiotica Srl
13.9. Lesaffre
13.10. Lactobio A/S (*LIST NOT EXHAUSTIVE)

14. Appendix

14.1. About Us and Services
14.2. Contact Us

02-2729-4219

+886-2-2729-4219

License/价格

全球后生元食品补充品市场 - 2024-2031

Global Postbiotics Food Supplements Market - 2024-2031

市场动态

COVID-19 影响分析

俄乌战争影响分析

按类型

按形式

按申请

按配销通路

按地区

主要进展

目录

第 1 章：方法与范围

第 2 章：定义与概述

第 3 章：执行摘要

第 4 章：动力学

第 5 章：产业分析

第 6 章：COVID-19 分析

第 7 章：按类型

第 8 章：按形式

第 9 章：按申请

第 10 章：按配销通路

第 11 章：按地区

第 12 章：竞争格局

第 13 章：公司简介

第 14 章：附录

Market Dynamics

COVID-19 Impact Analysis

Russia-Ukraine War Impact Analysis

By Type

By Form

By Application

By Distribution Channel

By Region

Key Developments

Competitive Landscape

Why Purchase the Report?

Table of Contents

1. Methodology and Scope

2. Definition and Overview

3. Executive Summary

4. Dynamics

5. Industry Analysis

6. COVID-19 Analysis

7. By Type

8. By Form

9. By Application

10. By Distribution Channel

11. By Region

12. Competitive Landscape

13. Company Profiles

14. Appendix